Informed consent is a process in which a health care provider educates a patient about the risks, benefits, and alternatives of a given procedure or intervention. The patient must be competent to make a voluntary decision about whether to undergo the said procedure. Informed consent is both an ethical and legal obligation of medical practitioners in the US and originates from the patient's right to direct what happens to his/her body. Implicit in providing informed consent is an assessment of the patient's understanding, rendering an actual recommendation, and documentation of the process. The Joint Commission requires documentation of all the elements of informed consent "in a form, progress notes or elsewhere in the record." The following are the required elements for documentation of the informed consent discussion: (1) the nature of the procedure, (2) the risks and benefits and the procedure, (3) reasonable alternatives, (4) risks and benefits of alternatives, and (5) assessment of the patient's understanding of elements 1 through 4.
It is the obligation of the provider to make it clear that the patient is participating in the decision-making process and avoid making the patient feel forced to agree to with the provider. The provider must make a recommendation and provide his/her reasoning for said recommendation.
Adequacy of Informed Consent
The required standard for informed consent is determined by the state. The three acceptable legal approaches to adequate informed consent are (1) Subjective standard: What would this patient need to know and understand to make an informed decision? (2) Reasonable patient standard: What would the average patient need to know to be an informed participant in the decision? (3) Reasonable physician standard: What would a typical physician say about this procedure?
Many states use the "reasonable patient standard" because it focuses on what a typical patient would need to know to understand the decision at hand. However, it is the sole obligation of the provider to determine which approach is appropriate for a given situation.
Exceptions to Informed Consent
Several exceptions to the requirement for informed consent include (1) the patient is incapacitated, (2) life-threatening emergencies with inadequate time to obtain consent, and (3) voluntary waived consent. If the patient's ability to make decisions is questioned or unclear, an evaluation by a psychiatrist to determine competency may be requested. A situation may arise in which a patient cannot make decisions independently but has not designated a decision maker. In this instance, the hierarchy of decision makers, which is determined by each state's laws, must be sought to determine the next legal surrogate decision maker. If this is unsuccessful, a legal guardian may need to be appointed by the court.
Children and Informed Consent
Children (typically under 17) do not have the ability to provide informed consent. As such, the parents must give permission for treatments or interventions. In this case, it not termed "informed consent" but "informed permission." An exception to this rule is a legally emancipated child who may provide informed consent for himself. Some, but not all, examples of an emancipated minor include minors who are (1) under 18 and married, (2) serving in the military, (3) able to prove financial independence or (4) mothers of children (married or not). Legislation regarding minors and informed consent is state-based as well. It is important to understand the state laws.
Informed consent is required for many aspects of health care. These include consent for:
Obtaining informed consent in medicine is process that should include: (1) describing the proposed intervention, (2) emphasizing the patient's role in decision-making, (3) discussing alternatives to the proposed intervention, (4) discussing the risks of the proposed intervention and (5) eliciting the patient's preference (usually by signature). Discussion of all risks is paramount to informed consent in this context. Most consent includes general risks, risks specific to the procedure, risks of no treatment and alternatives to treatment. Additionally, many consent forms express that there are no guarantees that the proposed procedure will provide a cure to the problem being addressed.
Patient safety is a major focus in health care, and effective informed consent is considered a patient safety issue. The Joint Commission recently addressed the challenges to ensuring effective informed consent. The emphasis of a patient signature as an indication of understanding is being called into question. The process of informed consent is shifting to focus more on communication and less on signatures. Studies of informed consent have found that there are many barriers to obtaining effective informed consent. One major barrier is that some consent forms contain language that is at too high a reading level for many patients. Use of visual and digital communication tools is being encouraged to address some the inefficiencies in the process of obtaining consent. Patients should be actively engaged as a way to enhance communication and ensure patient safety and understanding.
Informed consent may be waived in emergency situations if there is no time to obtain consent or if the patient is unable to communicate and no surrogate decision maker is available. Also, not every procedure requires explicit informed consent. For example taking a patient's blood pressure is a part of many medical treatments. However, a discussion regarding the risks and benefits of using a sphygmomanometer usually is not required.
Clinical Significance in Human Clinical Studies
Informed consent is mandatory for all clinical trials involving human beings. The consent process must respect the patient's ability to make decisions and adhere the individual hospital rules for clinical studies. Adherence to ethical standards in study design and execution is usually monitored by an Institutional Review Board (IRB). The IRB was established in the United States in 1974 by the National Research Act which called for regulation in human research that was prompted by questionable research tactics used in the Tuskegee syphillis experiments and others. Ethical and safe research standards have been an area of federal and presidential interest since then, with the development of many organizations and task forces since 1974 dedicated to this topic alone. Valid informed consent for research must include three major elements: (1) disclosure of information, (2) competency of the patient (or surrogate) to make a decision, and (3) voluntary nature of the decision. US federal regulations require a full, detailed explanation of the study and its potential risks.
An IRB may waive informed consent if certain conditions are met. Paramount to this is that there be 'minimal risk' to the research participants. One example of minimal risk research is the assessment of interventions that normally occur in emergency situations. Examples of this include studying medications used for intubations in the emergency room or conducting a retrospective chart review.
Shared Decision Making
Informed consent is a collaborative process allowing patients and healthcare providers to make decisions together when more than one reasonable alternative exists, accounting for the patient’s unique preferences and priorities and the best scientific evidence available.
It is most appropriate in weighing the benefits and harms of invasive procedures, computed tomography (CT), and post-ED disposition including the use of thrombolytics for acute ischemic stroke, lumbar puncture to rule out subarachnoid hemorrhage, and CT for minor pediatric head injuries.
Shared decision-making (SDM) challenges in Emergency Medicine include patient, provider, system and evidence level limitations. Examples include: (1) if patients are capable of or willing to engage in decision making (2) if providers feel it provides more or less medico-legal protection, (3) if the Emergency Department is overwhelmed and time is of the essence to make decisions, and (4) if the facility lacks well-validated risk prediction tools to guide decision making.
|Consent for newborn screening: parents' and health-care professionals' experiences of consent in practice., Etchegary H,Nicholls SG,Tessier L,Simmonds C,Potter BK,Brehaut JC,Pullman D,Hayeems R,Zelenietz S,Lamoureux M,Milburn J,Turner L,Chakraborty P,Wilson B,, European journal of human genetics : EJHG, 2016 Jun 15 [PubMed PMID: 27302842]|
|Barriers to Change in the Informed Consent Process: A Systematic Literature Review., Hallinan ZP,Forrest A,Uhlenbrauck G,Young S,McKinney R Jr,, IRB, 2016 May-Jun [PubMed PMID: 27301167]|
|Informing Patients About Placebo Effects: Using Evidence, Theory, and Qualitative Methods to Develop a New Website., Greville-Harris M,Bostock J,Din A,Graham CA,Lewith G,Liossi C,O'Riordan T,White P,Yardley L,Bishop FL,, JMIR research protocols, 2016 Jun 10 [PubMed PMID: 27288271]|
|Staged-informed Consent in the Cohort Multiple Randomized Controlled Trial Design: Erratum.,, Epidemiology (Cambridge, Mass.), 2016 Jul [PubMed PMID: 27271294]|
|Documentation of decision-making capacity, informed consent, and health care proxies: a study of surrogate consent., Glezer A,Stern TA,Mort EA,Atamian S,Abrams JL,Brendel RW,, Psychosomatics, 2011 Nov-Dec [PubMed PMID: 22054621]|